Señales en vivo de OPNT | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 mar 2023 @ 16:00):

Stats
Volumen de hoy	562 778
Volumen promedio	72 355.00
Capitalización de mercado	108.80M
EPS	$0.110 ( 2023-03-21 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.16
ATR14	$0.278 (1.35%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-02	Silver Gabrielle Alison	Sell	21 343	Common Stock
2023-03-02	Silver Gabrielle Alison	Sell	2 500	Stock Option (right to buy)
2023-03-02	Silver Gabrielle Alison	Sell	2 000	Common Stock
2023-03-02	Silver Gabrielle Alison	Sell	2 500	Common Stock
2023-03-02	Silver Gabrielle Alison	Sell	2 500	Stock Option (right to buy)

INSIDER POWER
-97.68
Last 100 transactions
Buy: 31 334 \| Sell: 1 708 118

Volumen Correlación

Largo: 0.22 (neutral)

Corto: -0.75 (moderate negative)

Signal:(50.127) Neutral

Opiant Pharmaceuticals Correlación

10 Correlaciones Más Positivas
FFNW	0.988
SUMO	0.986
TAST	0.959
DSPG	0.953
MRTX	0.941
CLST	0.936
HCCI	0.933
STAY	0.931
NTUS	0.921
ISRG	0.921

10 Correlaciones Más Negativas
XPDI	-0.952
AHPI	-0.952
AXDX	-0.947
VRAY	-0.947
RNAZ	-0.941
SNAX	-0.938
OPI	-0.935
IRBT	-0.935
RELL	-0.933
PLL	-0.93

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Opiant Pharmaceuticals Correlación - Moneda/Commodity

0.74
( moderate )

0.72
( moderate )

-0.36
( neutral )

0.60
( weak )

-0.67
( moderate negative )

-0.35
( neutral )

Opiant Pharmaceuticals Finanzas

Annual	2021
Ingresos:	$40.73M
Beneficio Bruto:	$31.66M (77.74 %)
EPS:	$0.680

FY	2021
Ingresos:	$40.73M
Beneficio Bruto:	$31.66M (77.74 %)
EPS:	$0.680

FY	2020
Ingresos:	$27.40M
Beneficio Bruto:	$21.21M (77.39 %)
EPS:	$-0.440

FY	2019
Ingresos:	$38.24M
Beneficio Bruto:	$30.52M (79.81 %)
EPS:	$2.88

Financial Reports:

No articles found.

Opiant Pharmaceuticals

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.